In a highly patented field, IDC created an IP platform and rapidly developed disposable and reusable injector pens to provide affordable treatment for millions of Indians and position Wockhardt as a global player in the insulin market.
Competitor Analysis
When designing two insulin pens for a pharmaceutical giant in India, IDC understood that the injector pen had to be ground breaking in design with reduced production costs while delivering a higher standard of quality compared to the other products on the market.
IDC engineered a mechanism that used 100% plastic components in both their disposable and reusable pens.
The pens were configured for high-volume, local hand assembly, but can also be easily adapted to very high-volume automated assembly.
The Industrial Design of the pens is focused on giving the look and feel of a stylish object, taking away the clinical drug delivery appearance, which makes it more aesthetically pleasing to use.
Prototypes were produced by IDC Models to test the concepts developed by IDC's design and engineering team.
SLA Prototype
Dose Accuracy Test
Both pens allow for 1 to 60 units of insulin to be dialled up and, with forward pressure on a thumb pad, the drive mechanism is activated and the set dose is administered.
The pens were designed to meet UL and FDA approvals, as well as, ISO 11608 1, 2 & 3 certification.
Design Validation
Final Product
Wockhardt's Insulin Injector Pen is produced at a rate of 2.5 million units per year and IDC's design ensures the best quality while keeping the cost of production low.
The injector pen was awarded the World Star for Packaging Award, the Asian Star for Packaging Award, and the Innovation & Design Excellence Award 2008.